NephroGenex

NephroGenex

Drug-development company focusing on kidney disease and progression of diabetic kidney disease. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€4—5m (Dealroom.co estimates Jul 2010.)
Princeton New Jersey (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

$3.3m

Series A
N/A

$1.0m

Seed
N/A

N/A

IPO

$12.0m

Post IPO Equity
N/A

$5.5m

Post IPO Equity
Total Funding€3.9m

Recent News about NephroGenex

Edit
More about NephroGenexinfo icon
Edit

Nephrogenex operates as a legitimate online pharmacy, providing a comprehensive range of pharmaceutical products, including medications, herbal supplements, medical cosmetics, and medical equipment. The company caters to customers who prefer the convenience of ordering online rather than visiting physical pharmacies. Nephrogenex serves a global clientele, offering a user-friendly online catalog that is categorized for easy navigation and includes a search function by letter or name. The business model focuses on providing high-quality, original products and additional services such as reserving goods, assisting in finding medicines, and offering medical equipment not currently available. Revenue is generated through the sale of these pharmaceutical products and services. The company emphasizes customer satisfaction and cost-saving options, which contribute to its positive reviews and repeat business.

Keywords: online pharmacy, medications, supplements, medical equipment, global clientele, cost-saving, original products, customer satisfaction, convenient ordering, comprehensive catalog.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.